Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals (XENE) Tops Q3 EPS by 2c

November 10, 2021 4:24 PM EST

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.36), $0.02 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $8.12 million versus the consensus estimate of $10.22 million.

Cash and cash equivalents and marketable securities as of September 30, 2021 were $249.6 million, compared to $177.0 million as of... More